1. Home
  2. XLO vs SNYR Comparison

XLO vs SNYR Comparison

Compare XLO & SNYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • SNYR
  • Stock Information
  • Founded
  • XLO 2016
  • SNYR 2010
  • Country
  • XLO United States
  • SNYR United States
  • Employees
  • XLO N/A
  • SNYR N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • SNYR
  • Sector
  • XLO Health Care
  • SNYR
  • Exchange
  • XLO Nasdaq
  • SNYR NYSE
  • Market Cap
  • XLO 42.2M
  • SNYR 16.6M
  • IPO Year
  • XLO 2021
  • SNYR N/A
  • Fundamental
  • Price
  • XLO $0.69
  • SNYR $3.24
  • Analyst Decision
  • XLO Buy
  • SNYR Strong Buy
  • Analyst Count
  • XLO 1
  • SNYR 1
  • Target Price
  • XLO $4.00
  • SNYR $10.00
  • AVG Volume (30 Days)
  • XLO 625.2K
  • SNYR 107.3K
  • Earning Date
  • XLO 08-07-2025
  • SNYR 08-24-2025
  • Dividend Yield
  • XLO N/A
  • SNYR N/A
  • EPS Growth
  • XLO N/A
  • SNYR N/A
  • EPS
  • XLO N/A
  • SNYR 0.30
  • Revenue
  • XLO $9,274,000.00
  • SNYR $33,592,914.00
  • Revenue This Year
  • XLO $300.08
  • SNYR $37.83
  • Revenue Next Year
  • XLO $1.87
  • SNYR $18.39
  • P/E Ratio
  • XLO N/A
  • SNYR $10.75
  • Revenue Growth
  • XLO N/A
  • SNYR N/A
  • 52 Week Low
  • XLO $0.62
  • SNYR $0.36
  • 52 Week High
  • XLO $1.70
  • SNYR $10.00
  • Technical
  • Relative Strength Index (RSI)
  • XLO 46.69
  • SNYR N/A
  • Support Level
  • XLO $0.66
  • SNYR N/A
  • Resistance Level
  • XLO $0.70
  • SNYR N/A
  • Average True Range (ATR)
  • XLO 0.03
  • SNYR 0.00
  • MACD
  • XLO 0.01
  • SNYR 0.00
  • Stochastic Oscillator
  • XLO 81.13
  • SNYR 0.00

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About SNYR SYNERGY CHC CORP

Synergy CHC Corp is a provider of consumer health care, beauty, and lifestyle products. It is engaged in the business of marketing and distributing consumer branded products through various distribution channels in the health and wellness industry. The company's products include FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen amongst others. Flat Tummy is a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their nutrition and weight management goals.

Share on Social Networks: